The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked on Neuralink.

There is no credible evidence of any such announcement. An official from a drug-testing group said her organization is unaware of it.

Elon Musk has once again found himself at the center of controversy, as the tech billionaire continues to grapple with the fallout from a surge in sexualized deepfakes on his social platform X, while ...